BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11554781)

  • 1. Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor.
    Jenh CH; Cox MA; Hipkin W; Lu T; Pugliese-Sivo C; Gonsiorek W; Chou CC; Narula SK; Zavodny PJ
    Cytokine; 2001 Aug; 15(3):113-21. PubMed ID: 11554781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5.
    Legler DF; Loetscher M; Roos RS; Clark-Lewis I; Baggiolini M; Moser B
    J Exp Med; 1998 Feb; 187(4):655-60. PubMed ID: 9463416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue.
    Carlsen HS; Baekkevold ES; Johansen FE; Haraldsen G; Brandtzaeg P
    Gut; 2002 Sep; 51(3):364-71. PubMed ID: 12171958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states.
    Cox MA; Jenh CH; Gonsiorek W; Fine J; Narula SK; Zavodny PJ; Hipkin RW
    Mol Pharmacol; 2001 Apr; 59(4):707-15. PubMed ID: 11259614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1.
    Gunn MD; Ngo VN; Ansel KM; Ekland EH; Cyster JG; Williams LT
    Nature; 1998 Feb; 391(6669):799-803. PubMed ID: 9486651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
    Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
    Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
    Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
    Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release.
    Lisignoli G; Toneguzzi S; Piacentini A; Cattini L; Lenti A; Tschon M; Cristino S; Grassi F; Facchini A
    J Cell Physiol; 2003 Jan; 194(1):71-9. PubMed ID: 12447991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma.
    Jinquan T; Jing C; Jacobi HH; Reimert CM; Millner A; Quan S; Hansen JB; Dissing S; Malling HJ; Skov PS; Poulsen LK
    J Immunol; 2000 Aug; 165(3):1548-56. PubMed ID: 10903763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma.
    Jinquan T; Quan S; Jacobi HH; Jing C; Millner A; Jensen B; Madsen HO; Ryder LP; Svejgaard A; Malling HJ; Skov PS; Poulsen LK
    Blood; 2000 Aug; 96(4):1230-8. PubMed ID: 10942362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets.
    Johnston B; Kim CH; Soler D; Emoto M; Butcher EC
    J Immunol; 2003 Sep; 171(6):2960-9. PubMed ID: 12960320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.
    Amft N; Curnow SJ; Scheel-Toellner D; Devadas A; Oates J; Crocker J; Hamburger J; Ainsworth J; Mathews J; Salmon M; Bowman SJ; Buckley CD
    Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells.
    Husson H; Freedman AS; Cardoso AA; Schultze J; Munoz O; Strola G; Kutok J; Carideo EG; De Beaumont R; Caligaris-Cappio F; Ghia P
    Br J Haematol; 2002 Nov; 119(2):492-5. PubMed ID: 12406091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).
    Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD
    J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.
    Schaerli P; Willimann K; Lang AB; Lipp M; Loetscher P; Moser B
    J Exp Med; 2000 Dec; 192(11):1553-62. PubMed ID: 11104798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells.
    Spinetti G; Camarda G; Bernardini G; Romano Di Peppe S; Capogrossi MC; Napolitano M
    Biochem Biophys Res Commun; 2001 Nov; 289(1):19-24. PubMed ID: 11708770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
    Soejima K; Rollins BJ
    J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants.
    Goddard S; Williams A; Morland C; Qin S; Gladue R; Hubscher SG; Adams DH
    Transplantation; 2001 Dec; 72(12):1957-67. PubMed ID: 11773896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
    Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
    Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
    Tensen CP; Flier J; Van Der Raaij-Helmer EM; Sampat-Sardjoepersad S; Van Der Schors RC; Leurs R; Scheper RJ; Boorsma DM; Willemze R
    J Invest Dermatol; 1999 May; 112(5):716-22. PubMed ID: 10233762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.